Skip to content

CLINICAL STUDY TO ASSESS THE COMBINED EFFECT OF KUSHMANDA SWARASA, YAVA KSHARA AND GUDA IN RENAL CALCULI

AN OPEN-LABEL SINGLE ARM CLINICAL STUDY TO ASSESS THE COMBINED EFFECT OF KUSHMANDA SWARASA, YAVA KSHARA AND GUDA IN RENAL CALCULI

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037495
Enrollment
30
Registered
2021-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

None listed

Sponsors

Dr SHILPA S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between 20 - 50 years of age, irrespective of sex, religion, occupation, socioeconomic status, etc. 2. Evidence of renal calculi in kidney and/or renal pelvis assessed by USG report. 3. Calculi size of 5-10mm size, irrespective of number 4. May be associated with mild to moderate renal pain (may be radiating to flank & groin), nausea and vomiting, hematuria, increased frequency of mictuition or dysuria. 5. Paneeya kshara arhas

Exclusion criteria

Exclusion criteria: 1. Case of immediate surgical intervention 2. Patients of renal calculi diagnosed with complications like severe hydronephrosis, Glomerular nephritis and chronic renal failure. 3. Patients diagnosed with systemic illness like DM, HTN, TB, HIV, Hepatitis-B, syphilis and renal carcinoma 4. Paneeya kshara anarhas 5. Pregnant women

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of Kushmanda swarasa, Yava kshara and Guda in reducing the size and expulsion of renal calculi assessed by USG report.Timepoint: Periodical clinical assessment will be done on 0, 15, 30 and 60 days

Secondary

MeasureTime frame
To evaluate the effect of Kushmanda swarasa, Yava kshara and Guda in reducing the pain, burning sensation and haematuria in renal calculi.Timepoint: Periodical clinical assessment will be done on 0, 15, 30 and 60 days

Countries

India

Contacts

Public ContactDr RABINARAYAN TRIPATHY

AMRITA SCHOOL OF AYURVEDA

rabinarayan@ay.amrita.edu8129292391

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026